Q103258494

Summary

Q103258494 is an interpellation^[1].

Key Facts

• Q103258494 authored Johan Hultberg^[2].
• Q103258494's instance of is recorded as interpellation^[3].
• Q103258494's part of the series is recorded as interpellations of the 2020-2021 legislative session of the Riksdag^[4].
• Q103258494's language of work or name is recorded as Swedish^[5].
• Q103258494's publication date is recorded as +2020-11-25T00:00:00Z^[6].
• Q103258494's significant event is recorded as debate^[7].
• Q103258494's main subject is recorded as medication^[8].
• Q103258494's work available at URL is recorded as http://data.riksdagen.se/dokument/H810181^[9].
• Q103258494's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H810181^[10].
• Q103258494's work available at URL is recorded as http://data.riksdagen.se/fil/A6CDF9A7-4F0C-4CDF-B2F4-5AF4FC2A5527^[11].
• Q103258494's applies to jurisdiction is recorded as Sweden^[12].
• Q103258494's legal citation of this text is recorded as ip. 2020/21:181^[13].
• Q103258494's title is recorded as Bättre tillgång till läkemedelsassisterad behandling vid opioidberoende^[14].
• Q103258494's addressee is recorded as Lena Hallengren^[15].
• Q103258494's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q103258494's copyright status is recorded as public domain^[17].
• Q103258494's Swedish Riksdag document ID is recorded as H810181^[18].

Body

Works and Contributions

Q103258494 authored Johan Hultberg^[2].